Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;131(6):675-684.
doi: 10.1111/bju.15975. Epub 2023 Feb 6.

'Nocturomics': transition to omics-driven biomarkers of nocturia, a systematic review and future prospects

Susan Gong  1 , George Bou Kheir  2 , Abdo Kabarriti  1 , Lakshay Khosla  1 , Fred Gong  1 , Erik Van Laecke  2 , Jeffrey Weiss  1 , Karel Everaert  2 , François Hervé  2
Affiliations

'Nocturomics': transition to omics-driven biomarkers of nocturia, a systematic review and future prospects

Susan Gong et al. BJU Int. 2023 Jun.

Abstract

Objective: To systematically review studies that investigated different biomarkers of nocturia, including omics-driven biomarkers or 'Nocturomics'.

Materials and methods: PubMed® , Scopus® , and Embase® were searched systematically in May 2022 for research papers on biomarkers in physiological fluids and tissues from patients with nocturia. A distinction was made between biomarkers or candidates discovered by omics techniques, referred to as omics-driven biomarkers, and classical biomarkers, measured by standard laboratory techniques and mostly thought from pathophysiological hypothesis.

Results: A total of 13 studies with 18 881 patients in total were included, eight of which focused on classical biomarkers including: atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), C-reactive protein (CRP), aldosterone, and melatonin. Five were 'Nocturomics', including one that assessed the microbiome and identified 27 faecal and eight urinary bacteria correlated with nocturia; and four studies that identified candidate metabolomic biomarkers, including fatty acid metabolites, serotonin, glycerol, lauric acid, thiaproline, and imidazolelactic acid among others. To date, no biomarker is recommended in clinical practice. Nocturomics are in an embryonic phase of conception but are developing quickly. Although candidate biomarkers are being identified, none of them are yet validated on a large sample, although some preclinical studies have shown a probable role of fatty acid metabolites as a possible biomarker of circadian rhythm and chronotherapy.

Conclusion: Further research is needed to validate biomarkers for nocturia within the framework of a diagnostic and therapeutic precision medicine perspective. We hope this study provides a summary of the current biomarker discoveries associated with nocturia and details future prospects for omics-driven biomarkers.

Keywords: #Urology; Nocturomics; biomarker; metabolomics; microbiome; nocturia.

PubMed Disclaimer

Comment in

  • Benign Prostatic Hyperplasia.
    Kaplan SA. Kaplan SA. J Urol. 2024 Jan;211(1):183-185. doi: 10.1097/JU.0000000000003731. Epub 2023 Oct 20. J Urol. 2024. PMID: 37861092 No abstract available.

References

    1. Hashim H, Blanker MH, Drake MJ et al. International continence society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn 2019; 38: 499-508
    1. Holm-Larsen T. The economic impact of nocturia. Neurourol Urodyn 2014; 33(Suppl 1): S10-4
    1. Weiss JP, Everaert K. Management of Nocturia and Nocturnal Polyuria. Urology 2019; 1: 24-33
    1. Jayadevappa R, Newman DK, Chhatre S, Wein AJ. Medication adherence in the management of nocturia: Challenges and solutions. Patient Prefer Adherence 2015; 9: 77-85
    1. Nie Y, Wu XL. Getting back to the nature of the microbial world: From the description and inductive reasoning to deductive study after ‘meta-omics’. Microb Biotechnol 2021; 14: 22-5

Publication types

LinkOut - more resources